People living with inflammatory bowel disease (IBD) now have access to one of the newest, most advanced and minimally ...
A generic teduglutide reduced parenteral nutrition requirements in 96% of pediatric patients within 24 weeks in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results